Suppr超能文献

加纳库马西接受抗逆转录病毒治疗的艾滋病毒感染者中病毒载量未得到抑制的决定因素。

Determinants of viral load non-suppression among people living with HIV on anti-retroviral therapy in Kumasi, Ghana.

作者信息

Ansah David Ko, Kumah Emmanuel, Bawontuo Vitalis, Agyei-Baffour Peter, Afriyie Emmanuel K

机构信息

Faculty of Health and Allied Sciences, Catholic University College of Ghana, P.O. Box 363, Fiapre -Sunyani.

Policy, Planning, Monitoring & Evaluation Unit, Komfo Anokye Teaching Hospital, P.O. Box 1934, Kumasi, Ghana.

出版信息

Ghana Med J. 2021 Jun;55(2):111-117. doi: 10.4314/gmj.v55i2.3.

Abstract

OBJECTIVES

To determine the rate and factors associated with viral load non-suppression among adults living with HIV/AIDS on active anti-retroviral therapy (ART).

DESIGN

A retrospective cross-sectional study.

SETTING

Three ART clinics in Kumasi, Ghana.

PARTICIPANTS

All HIV-infected adults who were ≥18 years and on active ART for 12 months and whose viral load had been estimated were included.

MAIN OUTCOME MEASURE

Unsuppressed viral load among patients on ART.

RESULTS

In all, 483 HIV patients were included in the study, with 369 (76.4%) achieving viral load suppression. Gender, educational level, comorbidity status, and duration on ART were independently associated with viral non-suppression (p < 0.05).

CONCLUSIONS

This study has revealed that the rate of viral suppression in the study area is lower than the UNAIDS 90% target. The findings have implications on designing new and stemming up implementation of existing interventions to improve the rate of viral suppression among patients in the study area. It is also necessary that more of such studies are replicated in other parts of the country to identify risk factors for virological failure among patients on ART.

FUNDING

No funding was obtained for this study.

摘要

目的

确定接受抗逆转录病毒治疗(ART)的艾滋病病毒/艾滋病(HIV/AIDS)成年患者中病毒载量未被抑制的发生率及相关因素。

设计

一项回顾性横断面研究。

地点

加纳库马西的三家抗逆转录病毒治疗诊所。

参与者

纳入所有年龄≥18岁、接受ART治疗12个月且已进行病毒载量评估的HIV感染成年患者。

主要观察指标

接受ART治疗患者中未被抑制的病毒载量。

结果

该研究共纳入483例HIV患者,其中369例(76.4%)实现了病毒载量抑制。性别、教育水平、合并症状况及ART治疗时长与病毒载量未被抑制独立相关(p<0.05)。

结论

本研究表明,研究地区的病毒抑制率低于联合国艾滋病规划署设定的90%目标。这些发现对于设计新的干预措施以及加强现有干预措施的实施以提高研究地区患者的病毒抑制率具有重要意义。同样有必要在该国其他地区开展更多此类研究,以确定接受ART治疗患者病毒学失败的危险因素。

资金

本研究未获得资金支持。

相似文献

本文引用的文献

1
Living well with HIV.与艾滋病毒共存并活得健康。
Lancet HIV. 2019 Dec;6(12):e807. doi: 10.1016/S2352-3018(19)30379-0. Epub 2019 Nov 24.
2
The global burden of HIV and prospects for control.全球艾滋病病毒负担与控制前景。
Lancet HIV. 2019 Dec;6(12):e809-e811. doi: 10.1016/S2352-3018(19)30230-9. Epub 2019 Aug 19.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验